Cynthia Smith's Net Worth

$1.43 Million

Estimate Recalculated Jul 3, 2024 03:37PM EST

Who is Cynthia Smith?

Cynthia Smith has an estimated net worth of $1.43 Million. This is based on reported shares across multiple companies, which include Dicerna Pharmaceuticals Inc, ZS Pharma, Inc., Nivalis Therapeutics, Inc., Spero Therapeutics, Inc., Protara Therapeutics, Inc., Akebia Therapeutics, Inc., and AGIOS PHARMACEUTICALS, INC..

SEC CIK

Cynthia Smith's CIK is 0001609480

Past Insider Trading and Trends

2021 was Cynthia Smith's most active year for acquiring shares with 10 total transactions. Cynthia Smith's most active month to acquire stocks was the month of May. 2015 was Cynthia Smith's most active year for disposing of shares, totalling 9 transactions. Cynthia Smith's most active month to dispose stocks was the month of November. 2015 saw Cynthia Smith paying a total of $1,037,754.80 for 29,030 shares, this is the most they've acquired in one year. In 2015 Cynthia Smith cashed out on 282,919 shares for a total of $1,133,820.00, their largest year based on trade value.

Attention insiders: Dive deeper into market movements and stay ahead of the curve with Benzinga Pro! From up-to-the-second news to audio squawks and interactive data tools, it's everything you need to supercharge your trading strategy. Experience the Benzinga Pro advantage today and transform the way you trade with our exclusive free trial!

Dicerna Pharmaceuticals Inc No price found

Investor

Form Type
Δ Own
Qty.
Price
Size ($)
Own
Filing Date
Type
Is Scheduled
Trade Dates
Form 4
-100.00%
-3.33K
$38.25
-$127,487.25
0
Dec 28
Form 4
∞
3.33K
—
—
3.33K
Jun 3
Form 4
—
0
—
—
0
Jun 15
Form 4
—
0
—
—
0
Jun 20
Form 4
—
0
—
—
0
Aug 13
Form 3
—
0
—
—
0
No matching records found

ZS Pharma, Inc. No price found

Chief Commercial Officer

Form Type
Δ Own
Qty.
Price
Size ($)
Own
Filing Date
Type
Is Scheduled
Trade Dates
Form 4
-100.00%
-12.60K
$90.00
-$1,133,820.00
0
Dec 17
Form 4
∞
9.15K
$10.92
$100,011.05
9.15K
Dec 8
Form 4
—
0
—
—
0
Jun 18
Form 4
—
0
—
—
0
Jul 8
Form 3
—
0
—
—
0
No matching records found

Nivalis Therapeutics, Inc. (ALPN) Snapshot price: $27.1

Investor

Form Type
Δ Own
Qty.
Price
Size ($)
Own
Filing Date
Type
Is Scheduled
Trade Dates
Form 3
—
0
—
—
0
No matching records found

Spero Therapeutics, Inc. (SPRO) Snapshot price: $1.45

Investor

Form Type
Δ Own
Qty.
Price
Size ($)
Own
Filing Date
Type
Is Scheduled
Trade Dates
Form 4
+57.14%
20K
—
—
55K
May 29
Form 4
+133.33%
20K
—
—
35K
Oct 5
Form 4
∞
15K
—
—
15K
Sep 15
Form 4
—
0
—
—
0
Aug 17
Form 4
—
0
—
—
0
Jan 4
Form 4
—
0
—
—
0
Oct 27
Form 4
—
0
—
—
0
Jun 5
Form 4
—
0
—
—
0
Mar 29
Form 3
—
0
—
—
0
No matching records found

Protara Therapeutics, Inc. (TARA) Snapshot price: $2.9

Investor

Form Type
Δ Own
Qty.
Price
Size ($)
Own
Filing Date
Type
Is Scheduled
Trade Dates
Form 4
—
0
—
—
0
Jun 7
Form 4
—
0
—
—
0
Jun 7
Form 4
—
0
—
—
0
Jun 8
Form 4
—
0
—
—
0
Jun 9
Form 4
—
0
—
—
0
Jan 29
Form 3
—
0
—
—
0
No matching records found